
Andrew S Rosenthal
Examiner (ID: 18823, Phone: (571)272-6276 , Office: P/1613 )
| Most Active Art Unit | 1613 |
| Art Unit(s) | 1613 |
| Total Applications | 769 |
| Issued Applications | 375 |
| Pending Applications | 101 |
| Abandoned Applications | 323 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19768276
[patent_doc_number] => 20250049702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => INTRANASAL DELIVERY OF CANNABIDIOL TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/928283
[patent_app_country] => US
[patent_app_date] => 2024-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18928283
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/928283 | INTRANASAL DELIVERY OF CANNABIDIOL TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS | Oct 27, 2024 | Pending |
Array
(
[id] => 20254790
[patent_doc_number] => 12427123
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-30
[patent_title] => Phenylephrine hydrochloride compositions and containers
[patent_app_type] => utility
[patent_app_number] => 18/751134
[patent_app_country] => US
[patent_app_date] => 2024-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 8076
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18751134
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/751134 | Phenylephrine hydrochloride compositions and containers | Jun 20, 2024 | Issued |
Array
(
[id] => 19447148
[patent_doc_number] => 20240307278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => LYCOPENE COMPOSITIONS AND METHODS FOR PROTECTING SKIN AGAINST ULTRAVIOLET RADIATION
[patent_app_type] => utility
[patent_app_number] => 18/674999
[patent_app_country] => US
[patent_app_date] => 2024-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10415
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18674999
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/674999 | Lycopene compositions and methods for protecting skin against ultraviolet radiation | May 26, 2024 | Issued |
Array
(
[id] => 19510461
[patent_doc_number] => 20240342147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => MAGNESIUM PICOLINATE COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/659819
[patent_app_country] => US
[patent_app_date] => 2024-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11283
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18659819
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/659819 | MAGNESIUM PICOLINATE COMPOSITIONS AND METHODS OF USE | May 8, 2024 | Pending |
Array
(
[id] => 19860584
[patent_doc_number] => 20250099370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => INJECTABLE SLURRIES AND METHODS OF MANUFACTURING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/637772
[patent_app_country] => US
[patent_app_date] => 2024-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23917
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18637772
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/637772 | INJECTABLE SLURRIES AND METHODS OF MANUFACTURING THE SAME | Apr 16, 2024 | Abandoned |
Array
(
[id] => 19343624
[patent_doc_number] => 20240252587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => METHOD AND KIT FOR BOWEL PREPARATION
[patent_app_type] => utility
[patent_app_number] => 18/629406
[patent_app_country] => US
[patent_app_date] => 2024-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12415
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18629406
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/629406 | Method and kit for bowel preparation | Apr 7, 2024 | Issued |
Array
(
[id] => 20213481
[patent_doc_number] => 12410121
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => Cationic lipids for use in lipid nanoparticles
[patent_app_type] => utility
[patent_app_number] => 18/612888
[patent_app_country] => US
[patent_app_date] => 2024-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11295
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18612888
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/612888 | Cationic lipids for use in lipid nanoparticles | Mar 20, 2024 | Issued |
Array
(
[id] => 19510403
[patent_doc_number] => 20240342089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => AQUATIC LIPOSOMES ENCAPSULATING NATURAL COMPOUNDS AND MANUFACTURING METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/600544
[patent_app_country] => US
[patent_app_date] => 2024-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8134
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18600544
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/600544 | AQUATIC LIPOSOMES ENCAPSULATING NATURAL COMPOUNDS AND MANUFACTURING METHOD THEREOF | Mar 7, 2024 | Pending |
Array
(
[id] => 20142549
[patent_doc_number] => 12376863
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Embolic compositions
[patent_app_type] => utility
[patent_app_number] => 18/587736
[patent_app_country] => US
[patent_app_date] => 2024-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 11
[patent_no_of_words] => 1098
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18587736
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/587736 | Embolic compositions | Feb 25, 2024 | Issued |
Array
(
[id] => 19232080
[patent_doc_number] => 20240189271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => PHARMACEUTICAL COMPOSITIONS OF DIMETHYL FUMARATE
[patent_app_type] => utility
[patent_app_number] => 18/582320
[patent_app_country] => US
[patent_app_date] => 2024-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18582320
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/582320 | Pharmaceutical compositions of dimethyl fumarate | Feb 19, 2024 | Issued |
Array
(
[id] => 19707900
[patent_doc_number] => 20250018042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => INJECTABLE SLURRIES AND METHODS OF MANUFACTURING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/444413
[patent_app_country] => US
[patent_app_date] => 2024-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19587
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18444413
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/444413 | INJECTABLE SLURRIES AND METHODS OF MANUFACTURING AND USING THE SAME | Feb 15, 2024 | Pending |
Array
(
[id] => 19155954
[patent_doc_number] => 20240148660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => PROCESS FOR THE MANUFACTURE AND USE OF PANCREATIN MICROPELLET CORES
[patent_app_type] => utility
[patent_app_number] => 18/414007
[patent_app_country] => US
[patent_app_date] => 2024-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18414007
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/414007 | PROCESS FOR THE MANUFACTURE AND USE OF PANCREATIN MICROPELLET CORES | Jan 15, 2024 | Pending |
Array
(
[id] => 19096281
[patent_doc_number] => 20240115508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => NANOCRYSTALS, COMPOSITIONS, AND METHODS THAT AID PARTICLE TRANSPORT IN MUCUS
[patent_app_type] => utility
[patent_app_number] => 18/529962
[patent_app_country] => US
[patent_app_date] => 2023-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 296
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18529962
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/529962 | Nanocrystals, compositions, and methods that aid particle transport in mucus | Dec 4, 2023 | Issued |
Array
(
[id] => 19139632
[patent_doc_number] => 20240138392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => Formula for Enhancing the Detectability of Fishing Lures
[patent_app_type] => utility
[patent_app_number] => 18/383621
[patent_app_country] => US
[patent_app_date] => 2023-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2754
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18383621
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/383621 | Formula for Enhancing the Detectability of Fishing Lures | Oct 24, 2023 | Pending |
Array
(
[id] => 19018992
[patent_doc_number] => 20240075163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => NOVEL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 18/493428
[patent_app_country] => US
[patent_app_date] => 2023-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20399
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18493428
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/493428 | NOVEL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS | Oct 23, 2023 | Pending |
Array
(
[id] => 19402026
[patent_doc_number] => 20240285537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => COMPOSITIONS COMPRISING PGI2-RECEPTOR AGONISTS AND PROCESSES FOR THE PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/491529
[patent_app_country] => US
[patent_app_date] => 2023-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18491529
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/491529 | COMPOSITIONS COMPRISING PGI2-RECEPTOR AGONISTS AND PROCESSES FOR THE PREPARATION THEREOF | Oct 19, 2023 | Pending |
Array
(
[id] => 19096389
[patent_doc_number] => 20240115616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => METHOD FOR TREATING LIVER CIRRHOSIS BY USING COMPOSITION COMPRISING MESENCHYMAL STEM CELL, EXTRACELLULAR VESICLE PRODUCED BY MESENCHYMAL STEM CELL, AND GROWTH FACTOR
[patent_app_type] => utility
[patent_app_number] => 18/376545
[patent_app_country] => US
[patent_app_date] => 2023-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8550
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18376545
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/376545 | METHOD FOR TREATING LIVER CIRRHOSIS BY USING COMPOSITION COMPRISING MESENCHYMAL STEM CELL, EXTRACELLULAR VESICLE PRODUCED BY MESENCHYMAL STEM CELL, AND GROWTH FACTOR | Oct 3, 2023 | Pending |
Array
(
[id] => 19081804
[patent_doc_number] => 20240108605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => MAZINDOL COMBINATION IN THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY
[patent_app_type] => utility
[patent_app_number] => 18/480331
[patent_app_country] => US
[patent_app_date] => 2023-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18480331
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/480331 | MAZINDOL COMBINATION IN THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY | Oct 2, 2023 | Abandoned |
Array
(
[id] => 18860058
[patent_doc_number] => 20230414492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => INTRANASAL DELIVERY OF CANNABIDIOL TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/244391
[patent_app_country] => US
[patent_app_date] => 2023-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18244391
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/244391 | INTRANASAL DELIVERY OF CANNABIDIOL TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS | Sep 10, 2023 | Abandoned |
Array
(
[id] => 18860408
[patent_doc_number] => 20230414842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => METHOD FOR REDUCING TRANSMISSION OF DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/463338
[patent_app_country] => US
[patent_app_date] => 2023-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18463338
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/463338 | METHOD FOR REDUCING TRANSMISSION OF DISEASES | Sep 7, 2023 | Pending |